Clinical Trial Update: Evaluation of PATHFAST-LAM as a Tuberculosis Treatment Monitoring Tool in Kenya

View source ↗

Summary

A clinical trial evaluating PATHFAST-LAM as a treatment-monitoring tool for tuberculosis in Kenya, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis
• Tuberculosis

Snippet

Sponsor: Nagasaki University | Conditions: Tuberculosis, Pulmonary Tuberculoses | Status: NOT_YET_RECRUITING